MedPath

Aveed

These highlights do not include all the information needed to use AVEED safely and effectively.  See full prescribing information for AVEED. AVEED (testosterone undecanoate) injection,    CIIIInitial U.S. Approval: 1953

Approved
Approval ID

f80f025b-17d8-40af-8739-20ce07902045

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 24, 2021

Manufacturers
FDA

Endo Pharmaceuticals Inc.

DUNS: 178074951

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

testosterone undecanoate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67979-511
Application NumberNDA022219
Product Classification
M
Marketing Category
C73594
G
Generic Name
testosterone undecanoate
Product Specifications
Route of AdministrationINTRAMUSCULAR
Effective DateJanuary 10, 2023
FDA Product Classification

INGREDIENTS (3)

TESTOSTERONE UNDECANOATEActive
Quantity: 250 mg in 1 mL
Code: H16A5VCT9C
Classification: ACTIB
CASTOR OILInactive
Code: D5340Y2I9G
Classification: IACT
BENZYL BENZOATEInactive
Code: N863NB338G
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Aveed - FDA Drug Approval Details